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Abstract⎯Catalytic antibodies are a promising model for creating highly specific biocatalysts with predeter-
mined activity. However, in order to realize the directed change or improve their properties, it is necessary to
understand the basics of catalysis and the specificity of interactions with substrates. In the present work, a
structural and functional study of the Fab fragment of antibody A5 and a comparative analysis of its properties
with antibody A17 have been carried out. These antibodies were previously selected for their ability to interact with
organophosphorus compounds via covalent catalysis. It has been established that antibody A5 has exceptional
specificity for phosphonate X with bimolecular reaction rate constants of 510 ± 20 and 390 ± 20 min–1M–1 for
kappa and lambda variants, respectively. 3D-Modeling of antibody A5 structure made it possible to establish
that the reaction residue L-Y33 is located on the surface of the active site, in contrast to the A17 antibody, in
which the reaction residue L-Y37 is located at the bottom of a deep hydrophobic pocket. To investigate a
detailed mechanism of the reaction, A5 antibody mutants with replacements L-R51W and H-F100W were
created, which made it possible to perform stopped-flow kinetics. Tryptophan mutants were obtained as Fab
fragments in the expression system of the methylotrophic yeast species Pichia pastoris. It has been established
that the effectiveness of their interaction with phosphonate X is comparable to the wild-type antibody. Using
the data of the stopped-flow kinetics method, significant conformational changes were established in the
phosphonate modification process. The reaction was found to proceed using the induced-fit mechanism; the
kinetic parameters of the elementary stages of the process have been calculated. The results present the pros-
pects for the further improvement of antibody-based biocatalysts.
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INTRODUCTION
Today, antibodies are widely used in medicine and
biotechnology due to their ability to specifically recog-
nize and bind antigens. The possibility to artificially
create antibodies against various compounds that have
no natural analogs is one reason why this area of sci-
ence receives constant attention. However, the func-
tions of antibodies are not limited to binding antigens.
In the late 20th century, the capacity of antibodies for
biocatalysis, which allows them to both bind and
destroy antigen, was discovered [1]. Currently, a con-
siderable amount of catalytic antibodies (abzymes)
that catalyze various chemical reactions, for which no
natural enzymes are known, has been produced [2]. In
connection with this, the application of catalytic anti-
bodies for neutralizing synthetic toxins creates broad
prospects in the treatment of chemical poisoning, in
particular organophosphate (OP) poisoning.
Earlier, the screening of a semi-synthetic library of
human immunoglobulin variable fragments using
p-nitrophenyl-8-methyl-8-azabicyclo[3.2.1]octa phenyl-
phosphonate (phosphonate X) enabled the selection of
a panel of recombinant single-chain antibodies capa-
ble of covalent interactions with organophosphates.
Antibodies A5 and A17 exhibited the highest activity;
L-Tyr33 and L-Tyr37 residues of A5 and A17, respec-
tively, were found to be covalently modified [3]. The
difference in the position of the key amino-acid resi-
due in the reaction center evidences the possible
implementation of different mechanisms of interac-
tions between the abzymes and the substrate. Anti-
Abbreviations: CDR, complementarity determining region;
FRW, framework region of the antibody variable domain; VH, vari-
able domain of heavy chain; VL, variable domain of light chain;
QM/MM, hybrid quantum mechanics/molecular mechanics
modeling; OP, organophosphates.
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